Status:
COMPLETED
Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
AMD
Cancer
Eligibility:
All Genders
50+ years
Brief Summary
Background: Age-related macular degeneration (AMD) and cataracts are two eye diseases. They were studied in the Age-Related Eye Disease Study (AREDS2) and the AREDS2 Follow-On study. These studies fo...
Detailed Description
Objective: The overall objective of this extended follow-up study is to provide data regarding the incidence of late age-related macular degeneration (AMD), cataract surgery and lung cancer in the app...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- To participate in this study, the potential participant must meet all of the following criteria:
- Previously enrolled in the AREDS2 and AREDS2 Follow-on protocols.
- Participant must be offered sufficient opportunity to review and to understand the informed consent form, agree to the form s contents and provide written informed consent.
- EXCLUSION CRITERIA:
- There are no Exclusion Criteria.
Exclusion
Key Trial Info
Start Date :
May 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 21 2019
Estimated Enrollment :
709 Patients enrolled
Trial Details
Trial ID
NCT03367767
Start Date
May 23 2018
End Date
March 21 2019
Last Update
March 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892